Patient and Physician Knowledge of Key Safety Messages
Completed
- Conditions
- Anticoagulation
- Interventions
- Behavioral: Rivaroxaban (Xarelto, BAY59-7939)
- Registration Number
- NCT01907048
- Lead Sponsor
- Bayer
- Brief Summary
This cross-sectional epidemiologic study measured physician and patient awareness and understanding of the key messages in the Xarelto prescriber guide and Xarelto patient alert card.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2227
Inclusion Criteria
Not provided
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Group 1 Rivaroxaban (Xarelto, BAY59-7939) Survey to measure physician awareness and understanding of the key messages in the prescriber guide. Group 2 Rivaroxaban (Xarelto, BAY59-7939) Survey to measure patient awareness and understanding of the key messages in the patient card.
- Primary Outcome Measures
Name Time Method Knowledge and understanding among physicians regarding key safety information contained in the prescriber guide assessed by web-based questionnaire Up to 18 months Knowledge and understanding of patients regarding the key safety information contained in the patient alert card assessed by paper-based questionnaire Up to 18 months
- Secondary Outcome Measures
Name Time Method